ABSTRACT
Human papillomavirus (HPV)-related diseases such as cervical cancer have become a public health problem that seriously threatens human health. In response to the action plan for the elimination of cervical cancer, this consensus, on the basis of the World Health Organization position paper on HPV vaccine (2017) and the latest advances in research at home and abroad, provides an overview of HPV pathogens and the clinical, epidemiological and vaccine aspects of HPV related diseases. Through a comprehensive and systematic introduction of HPV disease-related knowledge, we aim to improve the level of prevention and control of HPV related diseases, especially to provide systematic and comprehensive evidence-based basis for professionals to use HPV vaccine scientificly.
Subject(s)
Female , Humans , Consensus , Papillomaviridae , Papillomavirus Infections , Papillomavirus Vaccines , Therapeutic Uses , Uterine Cervical Neoplasms , Virology , VaccinationABSTRACT
Human papillomavirus (HPV)-related diseases such as cervical cancer are public health problems that threaten human health. In response to an action plan for the elimination of cervical cancer, we review the etiology, clinical features, and epidemiology of HPV-related diseases and HPV vaccinology. Our consensus statement is based on the World Health Organization position paper on HPV vaccines (2017) and on recent advances in Chinese and international HPV research. Its purpose is to strengthen HPV-related disease prevention and control by providing systematic, comprehensive evidence to enable health professionals use of HPV vaccine in a scientifically-appropriate manner that maximizes impact on disease.
ABSTRACT
Liver cancer is one of the most common cancers in China. The major risk factors are chronic infections of hepatitis B virus (HBV), hepatitis C virus (HCV), high exposure to aflatoxins. In addition, exposure to cyanotoxins and some preventable health behaviors are also recognized to contribute to liver cancer development. To relieve the disease burden, primary prevention of etiological interventions is an important strategy. Based on the liver cancer epidemiology in China and the effective evidences and results from the etiological interventions conduced in Chinese population domestically, the following strategies are recommended in the "Strategies of primary prevention of liver cancer: Expert Consensus (2018)" to promote the effective prevention of liver cancer in general population. Immunization with HBV vaccines, including the immune programs to neonates, infants and children born to mothers with different status of HBV infection. Antiviral therapies to the patients with chronic hepatitis B or hepatitis C. Avoiding or reducing the exposure to aflatoxins as well as the cyanotoxins. Changing harmful life style, including quitting smoking and limiting alcohol consumption etc.
Subject(s)
Humans , China , Consensus , Liver Neoplasms , Primary Prevention , MethodsABSTRACT
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine. Meningococcal conjugate vaccines immunization schedules vary by vaccine manufacturer, and often cause confusion in immunization practices. Based on the epidemiological characteristics of meningococcal disease, serogroup distribution of Neisseria meningitidis, and research progress on the immunogenicity and safety of meningococcal vaccines, we developed an experts' consensus on immunization with meningococcal vaccines to provide guidance for immunization providers and for centers for disease control and prevention staff.
Subject(s)
Humans , China , Consensus , Immunization , Meningococcal Infections , Meningococcal Vaccines , Vaccines, ConjugateABSTRACT
Meningococcal meningitis is an acute, severe respiratory infectious disease caused by Neisseria meningitidis. Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis. Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine containing meningococcal polysaccharide conjugate vaccine. This article reviews research progress on the efficacy, safety, and cost-effectiveness of meningococcal vaccines, particularly in the Chinese market, to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.
Subject(s)
Humans , China , Cost-Benefit Analysis , Meningitis, Meningococcal , Meningococcal Vaccines , Economics , Vaccines, ConjugateABSTRACT
Meningococcal meningitis is an acute,severe respiratory infectious disease caused by Neisseria meningitidis.Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis.Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine,meningococcal polysaccharide conjugate vaccine,and a combined vaccine containing meningococcal polysaccharide conjugate vaccine.This article reviews research progress on the efficacy,safety,and cost-effectiveness of meningococcal vaccines,particularly in the Chinese market,to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.
ABSTRACT
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine,meningococcal polysaccharide conjugate vaccine,and a combined vaccine.Meningococcal conjugate vaccines immunization schedules vary by vaccine manufacturer,and often cause confusion in immunization practices.Based on the epidemiological characteristics of meningococcal disease,serogroup distribution of Neisseria meningitidis,and research progress on the immunogenicity and safety of meningococcal vaccines,we developed an experts' consensus on immunization with meningococcal vaccines to provide guidance for immunization providers and for centers for disease control and prevention staff.
ABSTRACT
Meningococcal meningitis is an acute,severe respiratory infectious disease caused by Neisseria meningitidis.Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis.Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine,meningococcal polysaccharide conjugate vaccine,and a combined vaccine containing meningococcal polysaccharide conjugate vaccine.This article reviews research progress on the efficacy,safety,and cost-effectiveness of meningococcal vaccines,particularly in the Chinese market,to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.
ABSTRACT
Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine,meningococcal polysaccharide conjugate vaccine,and a combined vaccine.Meningococcal conjugate vaccines immunization schedules vary by vaccine manufacturer,and often cause confusion in immunization practices.Based on the epidemiological characteristics of meningococcal disease,serogroup distribution of Neisseria meningitidis,and research progress on the immunogenicity and safety of meningococcal vaccines,we developed an experts' consensus on immunization with meningococcal vaccines to provide guidance for immunization providers and for centers for disease control and prevention staff.
ABSTRACT
Pneumococcal disease is one of the serious global public health problems, and an important leading cause of the morbidity and mortality of children and adults in China. Currently, antibiotics are the most choices for its clinical treatment. However, antibiotic resistance of has become a severe problem around the world due to the wide use of antibiotics. Hence, the prevention of pneumococcal disease by using pneumococcal vaccines is of great importance. In this article, we reviewed the etiology, clinic, epidemiology, disease burden of pneumococcal disease, and the vaccinology of pneumococcal vaccines, based on the Pneumococcal Vaccines WHO Position Paper (2012) and other latest evidence globally, to introduce comprehensive knowledge of pneumococcal disease, and for the purpose to improve the capacity of the professionals working on pneumococcal disease control and prevention and to provide appropriate evidences of pneumococcal vaccine applications for people who are engaged in public health and immunization vaccination.
Subject(s)
Adult , Child , Humans , China , Epidemiology , Consensus , Pneumococcal Infections , Pneumococcal Vaccines , Public Health , Streptococcus pneumoniae , Allergy and Immunology , Vaccination , Vaccines, ConjugateABSTRACT
Liver cancer is one of the most common cancers in China. The major risk factors are chronic infections of hepatitis B virus (HBV), hepatitis C virus (HCV), high exposure to aflatoxins. In addition, exposure to cyanotoxins and some preventable health behaviors are also recognized to contribute to liver cancer development. To relieve the disease burden, primary prevention of etiological interventions is an important strategy. Based on the liver cancer epidemiology in China and the effective evidences and results from the etiological interventions conduced in Chinese population domestically, the following strategies are recommended in the "Strategies of primary prevention of liver cancer: Expert Consensus (2018)" to promote the effective prevention of liver cancer in general population. Immunization with HBV vaccines, including the immune programs to neonates, infants and children born to mothers with different status of HBV infection. Antiviral therapies to the patients with chronic hepatitis B or hepatitis C. Avoiding or reducing the exposure to aflatoxins as well as the cyanotoxins. Changing harmful life style, including quitting smoking and limiting alcohol consumption etc.